Acknowledgements
Thomas’ NHS
SICKLE CELL DISEASE, BLOOD
We acknowledge the additional contribution to the study design by the following individuals: John James (Chief Executive, Sickle Cell Society), Jemma Johns (Lead Consultant for Obstetric Haematology and Sickle Cell Disease, King’s College Hospital), Maria Chorozoglou (Senior Health Economist, University of Southampton) and Jo Howard (formerly Consultant Haematologist, Guy’s and St Thomas’ NHS Foundation Trust). Many thanks also to all the current and former principal investigators, local network clinical researchers and coordinators at our participating hospitals: Guy’s and St Thomas’ NHS Foundation Trust, Imperial College Healthcare NHS Trust, King’s College Hospital NHS Foundation Trust, Manchester University NHS Foundation Trust, St George’s University Hospitals NHS Foundation Trust, University Hospitals of Leicester NHS Trust, and Whittington Health NHS Trust.A further acknowledgement is due to the current and past members of the TAPS2 Trial Steering Committee: Professor Isabel Reading (chair) (Professorial Fellow in Medical Statistics & Director, Research Design Service South Central, University of Southampton), Dr Amma Kyei-Mensah (Consultant Obstetrician, Whittington Health NHS Trust), Dr Oseme Etomi (Consultant Obstetrician, Guy’s and St Thomas’ NHS Foundation Trust), and Lorna Williamson (formerly Medical and Research Director, NHS Blood and Transplant).Finally, we wish to acknowledge our patient PPI group who reviewed the research proposal and study documents and offered advice from the patients’ perspective.